Glend Llandtada - Philippines

“The FDA’s fast-tracking of X-ray facility licensing is an important step to combat COVID-19.”

Glend Llandtada, Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines FDA Alters Requirements for Radiation Licensing During COVID-19

Published on: December 17th, 2020

Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities

The FDA has issued FDA Circular No. 2020-035, which pertains to Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities. Under this Circular, any pending applications will be nullified, requiring new applications to be submitted. Below are the interim guidelines for the conduct of pre-licensing inspections of Health Physics teams of the CDRRHR of the FDA.

Note: This Circular shall take effect November 19th 2020

The following facilities applying use of radiation devices during COVID-19 measures:

  • Diagnostic X-ray Facilities
  • Therapeutic X-ray Facilities utilizing Medical Linear Accelerator
  • Dental X-ray Facilities
  • Industrial and Anti-Crime X-ray Facilities
  • Education and Research X-ray Facilities
  • Veterinary X-ray Facilities
  • Transportable X-ray Facilities
  • Magnetic Resonance Imaging Facilities

However, the FDA will resume pre-licensing inspections for Medical Linear Accelerators. This can be done either online or by virtual inspection. For other types of radiation facilities, authorization will be done using an interim radiation facility authorization process and will be verified with a post-licensing inspection when quarantine measures end.

Grow with US

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.

Blog Posts

Hong Kong Refines Medical Device Post-Market Surveillance Report Form

On December 29th, 2022, the Hong Kong Medical Device Division refined and updated their Post-Market Surveillance Report form.

Thailand FDA Provides Guidance on Classification of Physical Therapy Devices

On December 3rd, 2022, the Thailand FDA (TFDA) issued new regulation to re-classify Physical Therapy Devices as Class 1 medical devices.

Philippines FDA Issues Advisory Reiteration Against Unethical Business Practices

On December 29th, 2022 the Philippines FDA (PFDA) issued an advisory reiteration concerning unethical business practices, specifically in regards to companies that sell/manufacture Prescription Pharmaceutical Products and Medical Devices (PPPMD) and their relationship/interaction with healthcare professionals (HCPs).